CEP-28122 mesylate salt Catalog No.:M20814-C InChi: InChI=1S/C43H53N8O7P/c1-29(2)51(30(3)4)59(56-24-12-23-44)58-36-25-38(50-28-45-39-40(50)47-42(48-41(39)52)46-27-49(5)6)57-37(36)26-55-43(31-13-10-9-11-14-31

Name: CEP-28122 mesylate salt Catalog No.:M20814-C InChi: InChI=1S/C43H53N8O7P/c1-29(2)51(30(3)4)59(56-24-12-23-44)58-36-25-38(50-28-45-39-40(50)47-42(48-41(39)52)46-27-49(5)6)57-37(36)26-55-43(31-13-10-9-11-14-31
Brand: acenths.com
SKU: 97921308268
Price: 120.00 USD
Availability: InStock
Rating: 4.700200000000001 (20 reviews)

SKU: 97921308268

4.7

USD120.00 USD166.00

Pay in 4 interest-free payments of $30.00 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

InChi: InChI=1S/C43H53N8O7P/c1-29(2)51(30(3)4)59(56-24-12-23-44)58-36-25-38(50-28-45-39-40(50)47-42(48-41(39)52)46-27-49(5)6)57-37(36)26-55-43(31-13-10-9-11-14-31

Tumor growth is inhibited by Ponatinib in a dose-dependent manner compare to vehicle-treated mice

14-hexaen-10-yl]propanamide

Although AM095 almost completely blocks histamine release (100 mg/kg)

Curzerene inhibits glutathione S-transferase A1 (GSTA1) mRNA and protein expression

CEP-28122 mesylate salt Catalog No.:M20814-C InChi: InChI=1S/C43H53N8O7P/c1-29(2)51(30(3)4)59(56-24-12-23-44)58-36-25-38(50-28-45-39-40(50)47-42(48-41(39)52)46-27-49(5)6)57-37(36)26-55-43(31-13-10-9-11-14-31CEP 28122 mesylate salt, a diaminopyrimidine derivative, is a potent, selective, and orally bioavailable ALK inhibitor, with an IC50 value of 1. 9 nM for recombinant ALK kinase activity. CEP 28122 has antitumor activity in experimental models of ALK positive human cancers. CEP 28122 mesylate salt has good pharmacodynamic and pharmacokinetic activity. Product information CAS Number: 2070009 30 0 Molecular Weight: 635. 17 Formula: C29H39ClN6O6S Chemical

Exchange/Return Notes